CDC: Swine Influenza (Flu)
CDC: Guidance for Clinicians & Public Health Professionals (April 29, 2009)
Novel H1N1 Flu (Swine Flu) and Feeding your Baby: What Parents Should Know
Ethical Guidelines in Pandemic Influenza
Sarasota County Health Department
Interim Guidance—Pregnant Women and Swine Influenza: Considerations for Clinicians
CDC: Pandemic Influenza and Pregnant Women
Click on the following link for the entire document
Oseltamivir, zanamivir, amantadine, and rimantadine are all “Pregnancy Category C" medications,
indicating that no clinical studies have been conducted to assess the safety of these medications
for pregnant women. Only two cases of amantadine use for severe influenza illness during the
third trimester have been reported. However, both amantadine and rimantadine have been
demonstrated in animal studies to be teratogenic and embryotoxic when administered at
substantially high doses. Because of the unknown effects of influenza antiviral drugs on pregnant
women and their fetuses, these four drugs should be used during pregnancy only if the potential
benefit justifies the potential risk to the embryo or fetus; the manufacturers' package inserts
should be consulted. However, no adverse effects have been reported among women who
received oseltamivir or zanamivir during pregnancy or among infants born to such women."
1: Mullooly JP, Barker WH, Nolan TF Jr.
Risk of acute respiratory disease among pregnant women during influenza A epidemics.
Public Health Rep. 1986
Mar-Apr;101(2):205-11. PubMed PMID: 3083477; PubMed Central PMCID: PMC1477788.
2: Cox S, Posner SF, McPheeters M, Jamieson DJ, Kourtis AP, Meikle S.
Hospitalizations with respiratory illness among pregnant women during influenza
season. Obstet Gynecol. 2006 Jun;107(6):1315-22. PubMed PMID: 16738158.
3: Schanzer DL, Langley JM, Tam TW.
Influenza-attributed hospitalization rates among pregnant women in Canada 1994-2000.
J Obstet Gynaecol Can. 2007
Aug;29(8):622-9. PubMed PMID: 17714614.
4: Hartert TV, Neuzil KM, Shintani AK, Mitchel EF Jr, Snowden MS, Wood LB, Dittus
RS, Griffin MR.
Maternal morbidity and perinatal outcomes among pregnant women
with respiratory hospitalizations during influenza season.
Am J Obstet Gynecol.
2003 Dec;189(6):1705-12. PubMed PMID: 14710102.
5: Black SB, Shinefield HR, France EK, Fireman BH, Platt ST, Shay D; Vaccine
Safety Datalink Workgroup.
Effectiveness of influenza vaccine during pregnancy in preventing
hospitalizations and outpatient visits for respiratory illness in
pregnant women and their infants.
Am J Perinatol. 2004 Aug;21(6):333-9. PubMed PMID: 15311370.
6: Cox S, Posner SF, McPheeters M, Jamieson DJ, Kourtis AP, Meikle S.
Influenza and pregnant women: hospitalization burden, United States, 1998-2002.
J Womens Health (Larchmt). 2006 Oct;15(8):891-3. PubMed PMID: 17087611.
8: Longman RE, Johnson TR.
Viral respiratory disease in pregnancy.
Curr Opin Obstet Gynecol. 2007 Apr;19(2):120-5. Review. PubMed PMID: 17353679.
Knowledge, attitudes, and reported practices among obstetrician-gynecologists in the USA regarding antibiotic prescribing for upper respiratory tract infections.
Chamany S, Schulkin J, Rose CE Jr, Riley LE, Besser RE.
Infect Dis Obstet Gynecol. 2005 Mar;13(1):17-24.
PMID: 16040323 [PubMed - indexed for MEDLINE]
Return to INDEX